Skip to main content
Clinical Trials/NCT02294071
NCT02294071UnknownPhase 4

Prospective Comparative Study of the Efficacy of Common Antipyretic Treatments in Febrile Children

Lawson Health Research Institute0 sites120 target enrollmentStarted: December 2014Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Enrollment
120
Primary Endpoint
temperature reduction from baseline

Study Overview

Brief Summary

This study will examine in detail the immediate effects of three common treatments given to children with fevers to lower their temperature. Each child will be given either ibuprofen, acetaminophen, or a combination, and their temperature monitored at five-minute intervals. The temperature-lowering effects of each treatment will be compared to evaluate which is most effective.

Detailed Description

There is no substantial evidence that a fever lower than 41°C is harmful to the welfare of an otherwise healthy child, although they can be dangerous to children already in critical condition [1,2]. However, fevers in healthy children commonly cause anxiety in parents and caregivers, so parents and physicians often give antipyretic medications to lower the fever [3,4]. Ibuprofen and acetaminophen are two of the most commonly used medications in children. Most major pediatric medical associations agree about appropriate dosages for children, but give no clear guidelines on whether ibuprofen or acetaminophen should be used [3,5]. Physicians commonly make the decision between the two based on their personal opinions of the efficacy and safety of the medications, or based on habit [6]. Survey data shows that more than half of physicians use combinations of both acetaminophen and ibuprofen to treat fever, either simultaneously or on an alternating schedule, with a variety of dosing patterns [6]. A majority of physicians believed there were established guidelines supporting this use, but in fact there are not [6].

Combining the two medications is widely theorized to improve effectiveness, but clinical trials comparing combination treatments to ibuprofen and/or acetaminophen alone have shown inconsistent results [4,7-12]. Several pharmacodynamic studies have shown that ibuprofen and acetaminophen both produce their largest effects on temperature within the first hour following dosage [9,10,13-16]. Despite this, only one study has been performed examining the change in temperature at intervals shorter than 30 minutes, and that study used substandard monitoring methods [10].

This study will use gold-standard monitoring methods to take temperatures every five minutes through the first one to four hours of treatment. Understanding the pattern of temperature change in the acute stages after dosing will help settle the debate about the optimal medication choice for treating childrens' fevers.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
3 Years to 12 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • fever between 38 and 41 Celsius (inclusive) on presentation to ER
  • assessment by treating physician that patient requires antipyretic treatment

Exclusion Criteria

  • known allergy or hypersensitivity to either study medication
  • received any antipyretic medication in past eight hours
  • patient requires admission to hospital
  • co-morbidities indicating increased risk of complication
  • assessment by treating physician that patient is medically unsuitable for the study

Arms & Interventions

acetaminophen

Experimental

acetaminophen 15mg/kg (max 975mg)

Intervention: Acetaminophen (Drug)

ibuprofen

Experimental

ibuprofen 10mg/kg (max 600mg)

Intervention: Ibuprofen (Drug)

combination

Experimental

acetaminophen 15mg/kg (max 975mg) and ibuprofen 10mg/kg (max 600mg)

Intervention: Ibuprofen (Drug)

combination

Experimental

acetaminophen 15mg/kg (max 975mg) and ibuprofen 10mg/kg (max 600mg)

Intervention: Acetaminophen (Drug)

Outcomes

Primary Outcomes

temperature reduction from baseline

Time Frame: 4 hours

change in temperature from baseline at time of drug administration and at five minute intervals afterward for a minimum of one hour, maximum 4 hours

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Michael Rieder

Principal Investigator

Lawson Health Research Institute

Similar Trials

Completed
Phase 4
Influenza Vaccine in Pediatric Transplant SubjectsInfluenza
NCT00133510National Institute of Allergy and Infectious Diseases (NIAID)60
Terminated
Not Applicable
Effectiveness of the Astym Technique, the Graston Technique, and Therapeutic Ultrasound in the Treatment of Lateral Epicondylosis.Lateral EpicondylitisTennis ElbowPosterolateral Rotator Instability
NCT03234192NYU Langone Health21
Completed
Not Applicable
Effectiveness of Conservative Treatment in Patients With Thoracic and Lumbar Fractures Without Neurological DeficitThoracic Spine FractureThoracolumbar Burst FractureFracture of Spine, Level UnspecifiedSpine FusionSpine FractureSpine, Fracture Lumbar
NCT06059820Sklifosovsky Institute of Emergency Care40
Completed
Not Applicable
Treat Arterial Hypertension and Diabetes in Rural AfricaArterial HypertensionDiabetes
NCT00744458Cooperation Afrique223
Completed
Phase 3
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic SyndromeChildhood Acute Erythroleukemia (M6)Childhood Acute Megakaryocytic Leukemia (M7)Childhood Acute Monoblastic Leukemia (M5a)Childhood Acute Monocytic Leukemia (M5b)Childhood Acute Myeloblastic Leukemia With Maturation (M2)Childhood Acute Myeloblastic Leukemia Without Maturation (M1)Childhood Acute Myelomonocytic Leukemia (M4)Childhood Myelodysplastic Syndromesde Novo Myelodysplastic SyndromesRefractory Anemia With Excess BlastsRefractory Anemia With Excess Blasts in TransformationRefractory Anemia With Ringed SideroblastsSecondary Myelodysplastic SyndromesUntreated Childhood Acute Myeloid Leukemia and Other Myeloid MalignanciesChronic Myelomonocytic LeukemiaRefractory Anemia
NCT00002798National Cancer Institute (NCI)880